Plegridy (PEG-interferon β-1a) News

||||||||||  Plegridy (PEG-interferon β-1a) / Biogen
Enrollment change, Trial primary completion date:  Biogen Multiple Sclerosis Pregnancy Exposure Registry (clinicaltrials.gov) -  Aug 12, 2015
P=N/A, N=750, Recruiting,  Sponsor: Biogen
N=375 --> 750 | Trial primary completion date: Dec 2020 --> Dec 2023

||||||||||  Plegridy (PEG-interferon β-1a) / Biogen
Enrollment open, Real-world evidence, Real-world effectiveness, Real-world:  Plegridy Observational Program (clinicaltrials.gov) -  Mar 2, 2015
P=N/A, N=3000, Recruiting,  Sponsor: Biogen Idec
N=375 --> 750 | Trial primary completion date: Dec 2020 --> Dec 2023 Not yet recruiting --> Recruiting

||||||||||  Plegridy (PEG-interferon ?-1a) / Biogen
Trial completion:  Study to Evaluate the Pharmacokinetic Profiles of BIIB017 (Peginterferon Beta-1a) and Rebif (clinicaltrials.gov) -  Feb 2, 2015
P1, N=30, Completed,  Sponsor: Biogen Idec
Not yet recruiting --> Recruiting Recruiting --> Completed

||||||||||  Plegridy (PEG-interferon β-1a) / Biogen
Trial primary completion date:  Biogen Multiple Sclerosis Pregnancy Exposure Registry (clinicaltrials.gov) -  Jan 13, 2015
P=N/A, N=375, Recruiting,  Sponsor: Biogen Idec
Recruiting --> Completed Trial primary completion date: Jun 2020 --> Dec 2020

||||||||||  Plegridy (PEG-interferon ?-1a) / Biogen
Enrollment open:  Study to Evaluate the Pharmacokinetic Profiles of BIIB017 (Peginterferon Beta-1a) and Rebif (clinicaltrials.gov) -  Nov 20, 2014
P1, N=30, Recruiting,  Sponsor: Biogen Idec
Trial primary completion date: Jun 2020 --> Dec 2020 Not yet recruiting --> Recruiting

||||||||||  Plegridy (PEG-interferon ?-1a) / Biogen
Enrollment change, Trial withdrawal:  Frequency: Transition to Peginterferon Beta-1a (BIIB017) From Subcutaneous Interferon Therapy (clinicaltrials.gov) -  Nov 17, 2014
P4, N=0, Withdrawn,  Sponsor: Biogen Idec
Not yet recruiting --> Recruiting N=1200 --> 0 | Not yet recruiting --> Withdrawn

||||||||||  Plegridy (PEG-interferon ?-1a) / Biogen
Enrollment closed, Trial primary completion date:  Characterize Flu-like Symptoms in Relapsing Multiple Sclerosis Patients Transitioning From Non-Pegylated Interferon Beta (IFN-?) Therapies to Peginterferon Beta-1a (BIIB017) (clinicaltrials.gov) -  Nov 17, 2014
P3, N=200, Active, not recruiting,  Sponsor: Biogen Idec
N=1200 --> 0 | Not yet recruiting --> Withdrawn Recruiting --> Active, not recruiting | Trial primary completion date: Aug 2015 --> Nov 2015

||||||||||  Plegridy (PEG-interferon ?-1a) / Biogen
New P1 trial:  Study to Evaluate the Pharmacokinetic Profiles of BIIB017 (Peginterferon Beta-1a) and Rebif (clinicaltrials.gov) -  Oct 22, 2014
P1, N=30, Not yet recruiting,  Sponsor: Biogen Idec

||||||||||  Plegridy (PEG-interferon β-1a) / Biogen
Enrollment change, Trial withdrawal:  Using Optical Coherence Tomography (OCT) to Evaluate the Efficacy and Safety of PEGylated Interferon Beta-1a (BIIB017) in Patients With Relapsing Multiple Sclerosis (clinicaltrials.gov) -  Sep 15, 2014
P3, N=0, Withdrawn,  Sponsor: Johns Hopkins University
Recruiting --> Active, not recruiting | Trial primary completion date: Aug 2015 --> Nov 2015 N=120 --> 0 | Recruiting --> Withdrawn

||||||||||  Plegridy (PEG-interferon ?-1a) / Biogen
New P4 trial:  Frequency: Transition to Peginterferon Beta-1a (BIIB017) From Subcutaneous Interferon Therapy (clinicaltrials.gov) -  Sep 9, 2014
P4, N=1200, Not yet recruiting,  Sponsor: Biogen Idec

||||||||||  Plegridy (PEG-interferon β-1a) / Biogen
Real-world evidence, Real-world effectiveness, Real-world:  Plegridy Observational Program (clinicaltrials.gov) -  Sep 4, 2014
P=N/A, N=3000, Not yet recruiting,  Sponsor: Biogen Idec

||||||||||  Plegridy (PEG-interferon ?-1a) / Biogen
Trial completion:  Pharmacokinetic Study of Peginterferon Beta-1a in Japanese and Caucasian Adult Healthy Participants. (clinicaltrials.gov) -  Aug 12, 2014
P1, N=44, Completed,  Sponsor: Biogen Idec
N=120 --> 0 | Recruiting --> Withdrawn Active, not recruiting --> Completed

||||||||||  Plegridy (PEG-interferon β-1a) / Biogen
Enrollment closed:  Long-Term Safety and Efficacy Study of Peginterferon Beta-1a (clinicaltrials.gov) -  Jul 30, 2014
P3, N=1500, Active, not recruiting,  Sponsor: Biogen Idec
Active, not recruiting --> Completed Enrolling by invitation --> Active, not recruiting

||||||||||  Plegridy (PEG-interferon ?-1a) / Biogen
Enrollment change:  Peginterferon Beta-1a (BIIB017) Autoinjector Pharmacokinetic Study in Healthy Volunteers (clinicaltrials.gov) -  Jun 13, 2014
P1, N=55, Completed,  Sponsor: Biogen Idec
Enrolling by invitation --> Active, not recruiting N=30 --> 55

||||||||||  Plegridy (PEG-interferon ?-1a) / Biogen
New P1 trial:  A Multiple Dose Safety Study of PEG-IFN in Healthy Volunteers (clinicaltrials.gov) -  Apr 24, 2014
P1, N=69, Completed,  Sponsor: Biogen Idec

||||||||||  Plegridy (PEG-interferon β-1a) / Biogen
Trial completion:  ADVANCE: Efficacy and Safety Study of Peginterferon Beta-1a in Participants With Relapsing Multiple Sclerosis (clinicaltrials.gov) -  Apr 3, 2014
P3, N=1516, Completed,  Sponsor: Biogen Idec
N=30 --> 55 Active, not recruiting --> Completed

||||||||||  Plegridy (PEG-interferon ?-1a) / Biogen
Enrollment closed:  Pharmacokinetic Study of Peginterferon Beta-1a in Japanese and Caucasian Adult Healthy Participants. (clinicaltrials.gov) -  Feb 6, 2014
P1, N=44, Active, not recruiting,  Sponsor: Biogen Idec
Active, not recruiting --> Completed Not yet recruiting --> Active, not recruiting

||||||||||  Plegridy (PEG-interferon ?-1a) / Biogen
Enrollment open:  Characterize Flu-like Symptoms in Relapsing Multiple Sclerosis Patients Transitioning From Non-Pegylated Interferon Beta (IFN-?) Therapies to Peginterferon Beta-1a (BIIB017) (clinicaltrials.gov) -  Nov 20, 2013
P3, N=200, Recruiting,  Sponsor: Biogen Idec
Not yet recruiting --> Active, not recruiting Not yet recruiting --> Recruiting

||||||||||  Plegridy (PEG-interferon ?-1a) / Biogen
New P1 trial:  Pharmacokinetic Study of Peginterferon Beta-1a in Japanese and Caucasian Adult Healthy Participants. (clinicaltrials.gov) -  Nov 5, 2013
P1, N=44, Active, not recruiting,  Sponsor: Biogen Idec

||||||||||  Plegridy (PEG-interferon ?-1a) / Biogen
Trial completion:  Peginterferon Beta-1a (BIIB017) Autoinjector Pharmacokinetic Study in Healthy Volunteers (clinicaltrials.gov) -  Oct 31, 2012
P1, N=30, Completed,  Sponsor: Biogen Idec
Not yet recruiting --> Recruiting Active, not recruiting --> Completed

||||||||||  Plegridy (PEG-interferon ?-1a) / Biogen
New P1 trial:  Peginterferon Beta-1a (BIIB017) Autoinjector Pharmacokinetic Study in Healthy Volunteers (clinicaltrials.gov) -  May 31, 2012
P1, N=30, Completed,  Sponsor: Biogen Idec

||||||||||  Plegridy (PEG-interferon ?-1a) / Biogen
Trial completion:  A Single-Dose, Pharmacokinetic/Pharmacodynamic (PK/PD), & Safety Study of BIIB017 in Participants With Renal Impairment & Healthy Volunteers (clinicaltrials.gov) -  Aug 24, 2011
P1, N=35, Completed,  Sponsor: Biogen Idec
Active, not recruiting --> Completed Recruiting --> Completed



	Diseases Companies Products Productz Mechanisms of Action Sites